Nebula Research & Development LLC Xencor Inc Call Options Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
215Shares Held
71.8MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$268 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$220 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$183 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$128 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$94.7 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.44B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...